149 related articles for article (PubMed ID: 14719085)
1. Efficacy of 9-cis-retinoic acid and N-(4-hydroxyphenyl) retinamide alone and in combination in mammary cancer prevention.
Cope MB; Steele VE; Lubet RA; Eto I; Juliana MM; Hill DL; Grubbs CJ
Oncol Rep; 2004 Feb; 11(2):465-9. PubMed ID: 14719085
[TBL] [Abstract][Full Text] [Related]
2. 4-(hydroxyphenyl)retinamide selectively inhibits the development and progression of ductal hyperplastic lesions and carcinoma in situ in mammary gland.
Green A; Shilkaitis A; Christov K
Carcinogenesis; 1999 Aug; 20(8):1535-40. PubMed ID: 10426803
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone.
Ratko TA; Detrisac CJ; Mehta RG; Kelloff GJ; Moon RC
Cancer Res; 1991 Jan; 51(2):481-6. PubMed ID: 1824682
[TBL] [Abstract][Full Text] [Related]
4. Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyl)retinamide and ovariectomy.
McCormick DL; Mehta RG; Thompson CA; Dinger N; Caldwell JA; Moon RC
Cancer Res; 1982 Feb; 42(2):508-12. PubMed ID: 6459843
[TBL] [Abstract][Full Text] [Related]
5. Retinoids as chemopreventive agents for breast cancer.
Moon RC; Mehta RG; Detrisac CJ
Cancer Detect Prev; 1992; 16(1):73-9. PubMed ID: 1551141
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of MNU-induced mammary tumors in the mature rat by 4-HPR and tamoxifen.
Moon RC; Kelloff GJ; Detrisac CJ; Steele VE; Thomas CF; Sigman CC
Anticancer Res; 1992; 12(4):1147-53. PubMed ID: 1386970
[TBL] [Abstract][Full Text] [Related]
7. Prevention of methylnitrosourea-induced mammary cancers by 9-cis-retinoic acid and/or vitamin D3.
Cope MB; Steele VE; Eto I; Juliana MM; Hill DL; Grubbs CJ
Oncol Rep; 2002; 9(3):533-7. PubMed ID: 11956623
[TBL] [Abstract][Full Text] [Related]
8. Effect of reduced body weight gain on the evaluation of chemopreventive agents in the methylnitrosourea-induced mammary cancer model.
RodrÃguez-Burford C; Lubet RA; Eto I; Juliana MM; Kelloff GJ; Grubbs CJ; Steele VE
Carcinogenesis; 1999 Jan; 20(1):71-6. PubMed ID: 9934852
[TBL] [Abstract][Full Text] [Related]
9. Effects of body weight gain reduction resulting from chemopreventive agent treatment on mammary gland morphology.
RodrÃguez-Burford C; Steele VE; Anderson AS; Stockard CR; Weiss HL; Eto I; Johanning GL; Grizzle WE; Grubbs CJ
Nutr Cancer; 2002; 43(1):67-75. PubMed ID: 12467137
[TBL] [Abstract][Full Text] [Related]
10. Suppression of rat mammary cancer development by N-(4-hydroxyphenyl)retinamide (4-HPR) following surgical removal of first palpable tumor.
Moon RC; Pritchard JF; Mehta RG; Nomides CT; Thomas CF; Dinger NM
Carcinogenesis; 1989 Sep; 10(9):1645-9. PubMed ID: 2527636
[TBL] [Abstract][Full Text] [Related]
11. Effects of dietary N-(4-hydroxyphenyl)retinamide on N-nitrosomethylbenzylamine metabolism and esophageal tumorigenesis in the Fischer 344 rat.
Gupta A; Nines R; Rodrigo KA; Aziz RA; Carlton PS; Gray DL; Steele VE; Morse MA; Stoner GD
J Natl Cancer Inst; 2001 Jul; 93(13):990-8. PubMed ID: 11438564
[TBL] [Abstract][Full Text] [Related]
12. Dietary retinoids and carotenoids in rodent models of mammary tumorigenesis.
Moon RC; Constantinou AI
Breast Cancer Res Treat; 1997; 46(2-3):181-9. PubMed ID: 9478273
[TBL] [Abstract][Full Text] [Related]
13. Chemopreventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary mammary cancer in female rats.
Ratko TA; Detrisac CJ; Dinger NM; Thomas CF; Kelloff GJ; Moon RC
Cancer Res; 1989 Aug; 49(16):4472-6. PubMed ID: 2525951
[TBL] [Abstract][Full Text] [Related]
14. Chemopreventive activity of a C-glucuronide analog of N-(4-hydroxyphenyl) retinamide-O-glucuronide against mammary tumor development and growth.
Abou-Issa HM; Alshafie GA; Curley RW; Wong MF; Clagett-Dame M; Repa JJ; Sikri V
Anticancer Res; 1999; 19(2A):999-1004. PubMed ID: 10368645
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of new retinoids in the prevention of mammary cancers and correlations with short-term biomarkers.
Grubbs CJ; Lubet RA; Atigadda VR; Christov K; Deshpande AM; Tirmal V; Xia G; Bland KI; Eto I; Brouillette WJ; Muccio DD
Carcinogenesis; 2006 Jun; 27(6):1232-9. PubMed ID: 16344269
[TBL] [Abstract][Full Text] [Related]
16. Effect of short-term administration of N-(4-hydroxyphenyl)-all-trans-retinamide on chemically induced mammary tumors.
Silverman J; Katayama S; Radok P; Levenstein MJ; Weisburger JH
Nutr Cancer; 1983; 4(3):186-91. PubMed ID: 6221232
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of growth of established N-methyl-N-nitrosourea-induced mammary cancer in rats by retinoic acid and ovariectomy.
Lacroix A; Doskas C; Bhat PV
Cancer Res; 1990 Sep; 50(18):5731-4. PubMed ID: 2393847
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effect of N-(4-hydroxyphenyl)retinamide on N-methyl-N-nitrosourea-induced rat mammary cancer.
Dowlatshahi K; Mehta RG; Thomas CF; Dinger NM; Moon RC
Cancer Lett; 1989 Oct; 47(3):187-92. PubMed ID: 2534548
[TBL] [Abstract][Full Text] [Related]
19. Interactions between 4-HPR and diet in NMU-induced mammary tumorigenesis.
Cohen LA; Epstein M; Saa-Pabon V; Meschter C; Zang E
Nutr Cancer; 1994; 21(3):271-83. PubMed ID: 8072880
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapeutic evaluation of glucarate and N-(4-hydroxyphenyl)retinamide alone and in combination in the rat mammary tumor model.
Abou-Issa H; Webb TE; Minton JP; Moeschberger M
J Natl Cancer Inst; 1989 Dec; 81(23):1820-3. PubMed ID: 2531231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]